3 completed. 3 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
Follow Asthenia: new trials by email Literature Review of Asthenia trials Research Report on Asthenia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia Nuvastatic TM (C5OSEW5050ESA) 1000 mg - Asthenia, Cancer | Phase 2 / Phase 3 | Completed | Natureceuticals Sdn Bhd | 110 | 2017-09-02 | 2020-09-16 |
| Dopamine Agonist for Hemispatial Neglect and Motor Deficit Post Stroke Rotigotine - Right Hemisphere Stroke, Hemispatial Neglect | Phase 2 | Completed | University College, London | 20 | 2010-01-01 | 2011-02-21 |
| Clinical Trial of CoQ10 for Mild-to-Moderate Statin-Associated Muscle Symptoms Coenzyme Q10, Placebo - Pain, Weakness | Phase 2 / Phase 3 | Completed | Catherine Buettner | 68 | 2009-12-01 | 2017-01-23 |
Muscle Cramp (1) · Muscle Weakness (1) · Myalgia (1) · Myositis, Inclusion Body (1) · Neoplasms (1) · Neurologic Manifestations (1) · Pain (1) · Perceptual Disorders (1) · Stroke (1)
Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Nervous System Diseases (2) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cerebrovascular Disorders (1) · Muscular Diseases (1) · Musculoskeletal Diseases (1) · Musculoskeletal Pain (1) · Myositis (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Neuromuscular Diseases (1) · Neuromuscular Manifestations (1)
coenzyme Q10 (1) · rotigotine (1)
Catherine Buettner (1) · Natureceuticals Sdn Bhd (1) · University College, London (1)
India (1) · United Kingdom (1) · United States (1)
Catherine Buettner, MD, MPH (1) · Ghanashyam Biswas, PHD (1)
K23AR055664 (1)